Viewing nowOzatran Tablets 50 mg (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 200502189 · Notified 2005.09.20 · Insurance code 643501990
Treatment of hypertension and kidney disease in patients with type 2 diabetes and hypertension
This medication is used for the treatment of hypertension and is particularly beneficial in preventing and treating nephropathy in patients with type 2 diabetes. It effectively lowers blood pressure, reducing the risk of cardiovascular diseases and protecting kidney function. This efficacy contributes to the improvement of patients' health.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily, or the dose may be increased to up to 100 mg once daily if necessary. 3) If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed when administered concomitantly with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to up to 100 mg once daily, depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used blood-glucose-lowering medicines (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Older adults No adjustment of the initial dose is necessary for older adults aged 75 years or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with reduced effective intravascular volume For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see the Precautions for Use section). 4) Patients with hepatic impairment A lower dose should be considered for patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years and older who weigh 20 kg or more but less than 50 kg and can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Not recommended for pediatric patients under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.
This medication should not be taken by women who are pregnant, especially in the second and third trimesters, as it may cause serious harm to the fetus. Patients with severe liver or kidney impairment, those with certain hereditary diseases, and those allergic to this medication or its components should not use it. Caution should be exercised in elderly patients, those with elevated potassium levels, liver impairment, heart valve problems, and those at risk of acute drops in blood pressure, and regular testing is required. While this medication is generally safe, side effects such as dizziness, muscle cramps, back pain, upper respiratory infections, and nasal congestion may occur, and if symptoms persist or worsen, consult your physician. Severe allergic reactions, such as angioedema, have been reported infrequently, so if swelling of the face, lips, or tongue occurs, or if breathing difficulties arise, seek immediate treatment. When taking this medication with other antihypertensives, diuretics, or potassium supplements, potassium levels may dangerously increase; therefore, potassium supplements or salt substitutes should not be taken without consulting a physician. During treatment with this medication, periodic tests for blood pressure, kidney function, and electrolyte levels are necessary to monitor for abnormalities. Be cautious as blood pressure may drop too low, leading to dizziness or loss of consciousness, especially when starting treatment or increasing the dosage; if symptoms occur, notify the healthcare provider immediately. This medication is not recommended for breastfeeding women, and if it must be taken, cessation of breastfeeding is advised. In case of overdose, hypotension and rapid heartbeat may occur, so seek medical attention immediately if such symptoms arise. Store this medication out of reach of children, and avoid transferring it to other containers as it may affect the quality of the medication.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering, ideally at room temperature between 1 and 30 degrees Celsius. This storage method helps maintain the effectiveness of the medication.
White oval film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.